Trial Profile
EFFECTS OF THREE TREATMENT STRATEGIES ON ANEMIA AND QUALITY OF LIFE IN PATIENTS WITH SOLID TUMORS OR LYMPHOPROLIFERATIVE MALIGNANCIES: A RANDOMIZED 3-ARM STUDY ON ACTIVE (A) OR CONVENTIONAL (C) TRANSFUSIONS OR EPOETIN BETA (E). THE ACE STUDY.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 29 Aug 2011
Price :
$35
*
At a glance
- Drugs Epoetin beta (Primary) ; Iron sucrose
- Indications Chemotherapy-induced anaemia
- Focus Therapeutic Use
- Acronyms ACE
- Sponsors Roche
- 29 Aug 2011 New trial record